Peanut challenges prior to oral immunotherapy demonstrate high tolerance rates in selected patients
Background: Peanut oral immunotherapy (pOIT) protocols typically remain below the threshold for reaction during the initial dose escalation (IDE) day.However, some patients may have higher thresholds for reaction or may not have an ongoing peanut allergy.Objective: womens shirt We sought to characterize the response to an accelerated initial dose e